Take a free trial today. Take a free trial of Briefing In Play. Take a free trial of Briefing In Play Plus. Take a free trial of Briefing Trader. Learn about our premium services. Take a tour of our premium services. Can't Decide? Compare all services here. We are here to help, email customer service. We are here to help, call customer service. Take a free trial today. Take a free trial of Briefing In Play. Take a free trial of Briefing In Play Plus. Take a free trial of Briefing Trader. Learn about our premium services. Take a tour of our premium services. Can't Decide? Compare all services here. We are here to help, email customer service. We are here to help, call customer service.
[BRIEFING.COM] The S&P 500 hovers just above its flat line while the Russell 2000 (-0.3%) and Nasdaq Composite (-0.1%) trail the benchmark index. The Nasdaq has been pressured by biotechnology and chipmakers. The iShares Nasdaq Biotechnology ETF (IBB 311.82, -2.15)...
Scheduled, forward stock splits for public companies trading on the NYSE and NASDAQ.
Ticker Ratio Payable
HAIN 2-1 Dec 29
MARA 2-1 Dec 22
GNTX 2-1 Dec 31
In concluding my remarks on Tuesday, I said the conviction for buying on pullbacks had been M.I.A. so far in December. Well, thanks to the Fed's amazing grace, what had been lost has now been found. Since its low on Tuesday, the S&P 500 has advanced nearly 100 points...
 
Close
You are a paid subscriber. Please select the service you would like to access:
ProductPick